BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2021
View Archived Issues
Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders
Read More
SOCS1 is a major intracellular negative checkpoint of adoptive T-cell responses
Read More
Human mAbs prove a safe alternative to tetanus Ig for tetanus prevention and treatment in mice
Read More
Novel pleuromutilin derivatives with promising anti-MRSA activity
Read More
LAIR-1-targeting antibody NC-525 potentially effective against AML
Read More
Biomimetic synthesis of compounds from naturally abundant arglabin
Read More
SL-010110 inhibits gluconeogenesis and improves glucose homeostasis in diabetic mice
Read More
Topspin Therapeutics patents TMPRSS2 inhibitors
Read More
Autobahn Therapeutics divulges new thyromimetic compounds
Read More
Gilead Sciences identifies new LPAR1 antagonists
Read More
KSQ Therapeutics synthesizes USP1 inhibitors
Read More
Yumanity Therapeutics discloses PIKfyve inhibitors
Read More
Broader look reveals more contributions to chemotherapy damage
Read More
BiondVax signs agreements with Max Planck and UMG for COVID-19 NanoAbs
Read More
Novel aztreonam conjugates with promising activity against Gram-negative bacteria
Read More
Researchers present exosome-mediated system delivery of therapeutic cargo for HIV-1 repression
Read More
Claritas to develop R-107 for persistent pulmonary hypertension of the newborn
Read More
LogicBio nominates development candidate for treatment of hereditary tyrosinemia type 1
Read More